Lipids in the heart: A source of fuel and a source of toxins

Current Opinion in Lipidology

Volumn 18, Issue 3, 2007, Pages 277-282

  Park, Tae Sik ^a   Yamashita, Haruyo ^a   Blaner, William S ^a   Goldberg, Ira J ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

CD36; Heart; Lipoprotein; Lipoprotein lipase; Peroxisome proliferator activated receptor

Indexed keywords

CD36 ANTIGEN; FATTY ACID; LIPID; LIPOPROTEIN; RETINOID; RETINOL; THERMOZYMOCIDIN; TOXIN;

ATHEROSCLEROSIS; CONGESTIVE CARDIOMYOPATHY; DNA MODIFICATION; FATTY ACID TRANSPORT; GENE DELETION; HEART; HEART FAILURE; HUMAN; LIPID STORAGE; LIPID TRANSPORT; NONHUMAN; OBESITY; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIGENS, CD36; CARDIOMYOPATHIES; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; HEART; HUMANS; LIPID METABOLISM; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MODELS, BIOLOGICAL; MYOCARDIUM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;

EID: 34248370974     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32814a57db     Document Type: Review

References (29)

1. Pillutla P, Hwang YC, Augustus A, et al. Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy. Am J Physiol Endocrinol Metab 2005; 288:E1229-E1235.
2. Mardy K, Belke DD, Severson DL. Chylomicron metabolism by the isolated perfused mouse heart. Am J Physiol Endocrinol Metab 2001; 281:E357-E364.
3. Zhang YL, Hernandez-Ono A, Ko C, et al. Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnantlike emulsion particles. J Biol Chem 2004; 279:19362-19374.
4. Ziouzenkova O, Perrey S, Asatryan L, et al. Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Proc Natl Acad Sci USA 2003; 100:2730-2735.
5. Augustus AS, Buchanan J, Park TS, et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem 2006; 281:8716-8723. Despite increased uptake of glucose, hearts that have reduced LpL and lipoproteinderived fatty acid uptake are unable to compensate normally for aortic constriction and develop cardiac dysfunction with age.
6. Hajri T, Ibrahimi A, Coburn CT, et al. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 2001; 276:23661-23666.
7. Yu X, Burgess SC, Ge H, et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc Natl Acad Sci USA 2005; 102:1767-1772.
8. Sukonina V, Lookene A, Olivecrona T, Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA 2006; 103:17450-17455. Changes in LpL activity in adipose tissue with no change in protein mass occurs with feeding/fasting. This study shows that angiopoietin-like protein 4 may convert active LpL dimers into monomers and alter tissue LpL actions.
9. Colbert MC, Hall DG, Kimball TR, et al. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest 1997; 100:1958-1968.
10. de Paiva SA, Zornoff LA, Okoshi MP, et al. Ventricular remodeling induced by retinoic acid supplementation in adult rats. Am J Physiol Heart Circ Physiol 2003; 284:H2242-H2246.
11. Vogel S, Piantedosi R, O'Byrne SM, et al. Retinol-binding protein-deficient mice: biochemical basis for impaired vision. Biochemistry 2002; 41:15360-15368.
12. van Bennekum AM, Kako Y, Weinstock PH, et al. Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J Lipid Res 1999; 40:565-574.
13. Blaner WS, Obunike JC, Kurlandsky SB, et al. Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J Biol Chem 1994; 269:16559-16565.
14. Stowe KA, Burgess SC, Merritt M, et al. Storage and oxidation of long-chain fatty acids in the C57/BL6 mouse heart as measured by NMR spectroscopy. FEBS Lett 2006; 580:4282-4287. A novel noninvasive method to determine the fate of various mixtures of substrate for cardiac energy generation is presented.
15. Opie LH. Cardiac metabolism-emergence, decline, and resurgence. Part II. Cardiovasc Res 1992; 26:817-830.
16. Opie LH. Cardiac metabolism-emergence, decline, and resurgence. Part I. Cardiovasc Res 1992; 26:721-733.
17. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1:785-789.
18. Rodrigues B, Cam MC, Jian K, et al. Differential effects of streptozotocininduced diabetes on cardiac lipoprotein lipase activity. Diabetes 1997; 46:1346-1353.
19. Pulinilkunnil T, Rodrigues B. Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease. Cardiovasc Res 2006; 69:329-340. This is an excellent and comprehensive review of the role of LpL in diabetic hearts.
20. Buchanan J, Mazumder PK, Hu P, et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005; 146:5341-5349.
21. Gil-Ortega I, Carlos Kaski J. Diabetic miocardiopathy. Med Clin (Barc) 2006; 127:584-594.
22. Park SY, Cho YR, Finck BN, et al. Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver. Diabetes 2005; 54:2514-2524.
23. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23:201-229.
24. Boden G, Lebed B, Schatz M, et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50:1612-1617.
25. KankaanpaaM, Lehto HR, Parkka JP, et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006; 91:4689-4695. This paper describes investigations into the relationship between cardiac function and serum FFAs in obese individuals.
26. Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 2005; 115:547-555.
27. StanleyWC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85:1093-1129.
28. Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res 2004; 95:568-578.
29. Grynberg A, Demaison L. Fatty acid oxidation in the heart. J Cardiovasc Pharmacol 1996; 28 (Suppl 1):S11-S17.